ArticleCancer biology & therapy2014

Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab.

Li Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.